Serological responses in humans to the smallpox vaccine LC16m8
Open Access
- 1 October 2011
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 92 (10) , 2405-2410
Abstract
In response to potential bioterrorism with smallpox, members of the Japanese Self-Defense Forces were vaccinated with vaccinia virus (VACV) strain LC16m8, an attenuated smallpox vaccine derived from VACV strain Lister. The serological response induced by LC16m8 to four virion-surface proteins and the intracellular mature virus (IMV) and extracellular enveloped virus (EEV) was investigated. LC16m8 induced antibody response against the IMV protein A27 and the EEV protein A56. LC16m8 also induced IMV-neutralizing antibodies, but unlike the VACV strain Lister, did not induce either EEV-neutralizing antibody or antibody to EEV protein B5, except after revaccination. Given that B5 is the only target for EEV-neutralizing antibody and that neutralization of both IMV and EEV give optimal protection against orthopoxvirus challenge, these data suggest that immunity induced by LC16m8 might be less potent than that deriving from strain Lister. This potential disadvantage should be balanced against the advantage of the greater safety of LC16m8.Keywords
This publication has 33 references indexed in Scilit:
- Smallpox Vaccine Safety Is Dependent on T Cells and Not B CellsThe Journal of Infectious Diseases, 2011
- Smallpox vaccines: targets of protective immunityImmunological Reviews, 2010
- Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse ModelClinical and Vaccine Immunology, 2009
- Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on ComplementJournal of Virology, 2009
- Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and DryvaxJournal of General Virology, 2008
- LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from MonkeypoxJournal of Virology, 2006
- Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in MiceJournal of Virology, 2005
- An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia modelJournal of General Virology, 2005
- Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola virusesVirus Research, 1995
- Analysis of the nucleotide sequence of 53 kbp from the right terminus of the genome of variola major virus strain India-1967Virus Research, 1994